“RDIF announces the approval of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health of the Republic of Paraguay. The vaccine was registered under the emergency use authorisation procedure without additional clinical trials in the country”, RDIF said in a press release.

​Earlier, the vaccine was registered under the same procedure in Algeria, Argentina, Bolivia, Serbia, Palestine and Venezuela.

“Registration of Sputnik V vaccine in Paraguay proves the increasing interest of Latin American countries in a safe and effective Russian vaccine against coronavirus. We expect that more countries in the region will also approve it soon and are ready to create new partnerships to pool efforts in the fight against the pandemic”, RDIF CEO Kirill Dmitriev said, as quoted in the press release.

Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology, was registered by the Russian Health Ministry on 11 August, becoming the first registered vaccine against COVID-19 in the world.

The vaccine uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.